Matches in Wikidata for { <http://www.wikidata.org/entity/Q71580482> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q71580482 description "artículu científicu espublizáu en payares de 1981" @default.
- Q71580482 description "im November 1981 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71580482 description "scientific article published on 01 November 1981" @default.
- Q71580482 description "wetenschappelijk artikel" @default.
- Q71580482 description "наукова стаття, опублікована в листопаді 1981" @default.
- Q71580482 description "գիտական հոդված հրատարակված 1981 թվականի նոյեմբերի 1-ին" @default.
- Q71580482 name "[Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure]" @default.
- Q71580482 name "[Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure]" @default.
- Q71580482 type Item @default.
- Q71580482 label "[Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure]" @default.
- Q71580482 label "[Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure]" @default.
- Q71580482 prefLabel "[Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure]" @default.
- Q71580482 prefLabel "[Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure]" @default.
- Q71580482 P1433 Q71580482-7808E4F5-649D-4B78-BDC7-2C0DDA88F54C @default.
- Q71580482 P1476 Q71580482-6659D6CC-8B44-49D4-AB97-845BDCB559F2 @default.
- Q71580482 P2093 Q71580482-08FC5E71-8988-4256-8150-0351CEEC5A0E @default.
- Q71580482 P2093 Q71580482-45015D36-F1AD-4BFB-8A7A-EA65ACBEF375 @default.
- Q71580482 P2093 Q71580482-6BE865B1-90BB-428E-BB8F-A15A41FE8D0F @default.
- Q71580482 P2093 Q71580482-874B66A0-825F-400B-BA74-B886EFB6C9AD @default.
- Q71580482 P2093 Q71580482-CC7E878C-606B-456E-A8CA-0AC76B4E72B5 @default.
- Q71580482 P2093 Q71580482-F0195E4C-16EC-4EAC-91E4-424C2DA985E6 @default.
- Q71580482 P2093 Q71580482-F24F8FD0-EE08-47DD-BE0D-36047D968832 @default.
- Q71580482 P304 Q71580482-B1FA6654-8398-4C15-8AEB-CC91ADE42B59 @default.
- Q71580482 P31 Q71580482-5B8586D0-D9DA-431B-A0FF-0B21B1BDDDA6 @default.
- Q71580482 P433 Q71580482-D1D670C0-C0A6-495C-A34D-9A3C681BEEC1 @default.
- Q71580482 P478 Q71580482-D7B084B7-AC47-4EC8-B726-6AAC88A3CE52 @default.
- Q71580482 P577 Q71580482-492A481B-E50E-4338-B87A-44714B9AEA84 @default.
- Q71580482 P698 Q71580482-18DA0C10-29A7-48A4-A013-56DBF35F6427 @default.
- Q71580482 P698 6797371 @default.
- Q71580482 P1433 Q60100948 @default.
- Q71580482 P1476 "[Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure]" @default.
- Q71580482 P2093 "Boccalon H" @default.
- Q71580482 P2093 "Bounhoure JP" @default.
- Q71580482 P2093 "Cassagneau B" @default.
- Q71580482 P2093 "Fauvel JM" @default.
- Q71580482 P2093 "Giraud P" @default.
- Q71580482 P2093 "Kayanakis JG" @default.
- Q71580482 P2093 "Puel J" @default.
- Q71580482 P304 "1325-1332" @default.
- Q71580482 P31 Q13442814 @default.
- Q71580482 P433 "11" @default.
- Q71580482 P478 "74" @default.
- Q71580482 P577 "1981-11-01T00:00:00Z" @default.
- Q71580482 P698 "6797371" @default.